Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs SailPoint Inc. Common Stock (SAIL) Price & Performance

Oruka Therapeutics Inc. Common StockTrade
SailPoint Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Oruka Therapeutics Inc. Common Stock vs SailPoint Inc. Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while SailPoint Inc. Common Stock trades at $19 (market cap $11.06B). The key difference: SailPoint Inc. Common Stock is far larger — about 2.1× Oruka Therapeutics Inc. Common Stock's market cap, and SailPoint Inc. Common Stock is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and SailPoint Inc. Common Stock for 0 Days on average.

ORKASAIL
Market Cap
$5.18B$11.06B
Volume
490,7983,269,663
Sector
HealthTechnology
52-Week High
$113.08$22.85
52-Week Low
$26.19$10.49
Typical Hold Time
0 Days0 Days
Enterprise Value
$4.31B$10.76B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ORKA
100% Buy0% Sell
Avg holding period · 0 Days
SAIL
100% Buy0% Sell
Avg holding period · 0 Days

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →

About SailPoint Inc. Common Stock

SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.

Read more on SAIL →